Subject is participating in a concurrent study which may confound study results

Subject has a life expectancy <2 year

Subject is female of childbearing potential in whom pregnancy cannot be excluded

Subject with eGFR <30 mL/min/m2 (KDOQI classification - exclude class IV and above) and or on dialysis

Subject with a MI or CVA within 3 months prior to index procedure

Subject with known Connective Tissue Disease

Subject has a known hypersensitivity or contraindication to anticoagulants, antiplatelets, or contrast media, which is not amenable to post-treatment

Subject who has undergone prior endovascular or open surgical treatment for abdominal aortic aneurysm

Subject requires emergent aneurysm treatment, for example, trauma or rupture

Subject has a known hypersensitivity or allergies to study device implant material

Subject has an aneurysm that is:

Suprarenal, pararenal, or thoracoabdominal

Mycotic

Inflammatory

Pseudoaneurysm

Subject is presenting with thrombus or calcification of the proximal aneurysm neck: circumferential >50%

Pre-op stenosis of the renal arteries > 50%

Subject has active infection or history of COVID-19. History of COVID-19 is defined as availability of positive COVID-19 test with sequelae or hospitalization for treatment of COVID-19.